Diabetologia

, Volume 48, Issue 3, pp 496–505 | Cite as

High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFκB

  • H. Elouil
  • A. K. Cardozo
  • D. L. Eizirik
  • J. C. Henquin
  • J. C. Jonas
Article

Abstract

Aims/hypothesis

Hyperglycaemia and the pro-inflammatory cytokine IL-1β induce similar alterations of beta cell gene expression, including up-regulation of c-Myc and haeme-oxygenase 1. These effects of hyperglycaemia may result from nuclear factor-kappa B (NFκB) activation by oxidative stress. To test this hypothesis, we compared the effects of IL-1β, high glucose, and hydrogen peroxide, on NFκB DNA binding activity and target gene mRNA levels in cultured rat islets.

Methods

Rat islets were pre-cultured for 1 week in serum-free RPMI medium containing 10 mmol/l glucose, and further cultured in glucose concentrations of 5–30 mmol/l plus various test substances. Islet NFκB activity was measured by ELISA and gene mRNA expression was measured by RT-PCR.

Results

IL-1β consistently increased islet NFκB activity and c-Myc, haeme-oxygenase 1, inducible nitric oxide synthase (iNOS), Fas, and inhibitor of NFκB alpha (IκBα) mRNA levels. In comparison, 1- to 7-day culture in 30 mmol/l instead of 10 mmol/l glucose stimulated islet c-Myc and haeme-oxygenase 1 expression without affecting NFκB activity or iNOS and IκBα mRNA levels. Fas mRNA levels only increased after 1 week in 30 mmol/l glucose. Overnight exposure to hydrogen peroxide mimicked the effects of 30 mmol/l glucose on haeme-oxygenase 1 and c-Myc mRNA levels without activating NFκB. On the other hand, the antioxidant N-acetyl-l-cysteine inhibited the stimulation of haeme-oxygenase 1 and c-Myc expression by 30 mmol/l glucose and/or hydrogen peroxide.

Conclusions/interpretation

In contrast to IL-1β, high glucose and hydrogen peroxide do not activate NFκB in cultured rat islets. It is suggested that the stimulation of islet c-Myc and haeme-oxygenase 1 expression by 30 mmol/l glucose results from activation of a distinct, probably oxidative-stress-dependent signalling pathway.

Keywords

Antioxidant Glucose toxicity NFκOxidative stress Pancreatic beta cell 

Abbreviations

GSIS

Glucose-stimulated insulin secretion

HO

Haeme oxygenase

H2O2

Hydrogen peroxide

IκBα

Inhibitor of κB alpha

iNOS

inducible nitric oxide synthase

NAC

N-acetyl-l-cysteine

NFκB

Nuclear factor of kappa B chain

PKCβ2

Protein kinase C β2

TBP

TATA-box binding protein

Introduction

Type 2 diabetes results from the combination of insulin resistance and defective glucose-stimulated insulin secretion (GSIS) [1, 2]. This beta cell dysfunction seems to result from a moderate reduction in beta cell mass [3, 4] and profound functional alterations of the remaining beta cells [5, 6]. In contrast, type 1 diabetes is characterised by selective immune destruction of beta cells and subsequent lack of insulin secretion [7].

Chronic hyperglycaemia induces phenotypic alterations of rodent beta cells, including GSIS abnormalities, reduced expression of specific genes (loss of beta cell differentiation), hypertrophy, slight increase in apoptosis, and increased expression of genes normally repressed in fully differentiated beta cells [6, 8, 9, 10, 11, 12, 13, 14]. These phenotypic alterations may contribute to the progressive worsening of GSIS in type 2 diabetes [15, 16]. In comparison, in vitro exposure to inflammatory cytokines involved in the pathogenesis of type 1 diabetes, e.g. IL-1β, induces similar alterations of the beta cell phenotype [7, 17, 18]. These effects of IL-1β largely result from receptor-mediated activation of the transcription factor nuclear factor of kappa B chain (NFκB) [19, 20].

Among the genes induced by IL-1β and supraphysiological glucose concentrations, the transcription factor c-Myc stimulates apoptosis more than proliferation in rodent beta cells [21, 22, 23], whereas the antioxidant enzyme haeme-oxygenase 1 (HO1) improves beta cell survival under various stressful conditions [17, 24, 25, 26]. In vitro, overnight culture of rat islets in the presence of 30 mmol/l glucose (G30) instead of 10 mmol/l glucose (G10) markedly stimulated expression of HO1 and c-Myc at the mRNA and protein levels in a Ca2+- and cyclic AMP-dependent manner without affecting c-Myc or HO1 mRNA stability [27, 28]. Of note, culture in glucose concentrations lower than G10 (G2–G5), a stressful condition for rat beta cells, also stimulated islet HO1 and c-Myc expression. These V-shaped glucose concentration response curves for changes in islet c-Myc and HO1 expression with a minimum at G10 are similar to that of beta cell death [29]. Whereas the stimulation of beta cell apoptosis by prolonged culture in low glucose may be due to activation of AMP-dependent protein kinase and stimulation of c-Myc expression under these conditions [23, 30], it has been suggested that the deleterious effects of supraphysiological glucose concentrations on the beta cell phenotype result from NFκB activation by oxidative stress [12, 31, 32, 33, 34] or by induction of production and autocrine actions of IL-1β [35].

The aim of this study was to evaluate the role of NFκB activation in the changes of beta cell gene expression by high glucose concentrations. Therefore, we tested the effects of high glucose on both NFκB DNA binding activity and the mRNA levels of HO1, c-Myc and other NFκB target genes in cultured rat islets. These effects were compared to those of IL-1β, a positive control for NFκB activation and stimulation of NFκB target gene expression, and to those of hydrogen peroxide (H2O2), a positive control for oxidative stress. The effects of glucose and H2O2 were tested with and without addition of the antioxidant N-acetyl-l-cysteine (NAC).

Materials and methods

Materials

Human IL-1β was kindly provided by Dr. R.E. Aurigemma (National Cancer Institute Biological Resources Branch Preclinical Repository, Rockville, MD, USA), and diluted, aliquoted and stored as recommended. NAC, H2O2 and aminoguanidine hydrochloride were purchased from Merck (Darmstadt, Germany), Acros Organics (Geel, Belgium) and Sigma (St. Louis, MO, USA) respectively. The inhibitors of p38MAPK (SB203580) and of ERK activation (PD98059) were purchased from Campro scientific (Veenendaal, The Netherlands) and Research Biochemical International (Natick, MA, USA) respectively.

Islet isolation and culture

Male Wistar rats (180–200 g) were obtained from the animal facility of the Faculty of Medicine at the University of Louvain (Brussels, Belgium). Their pancreatic islets were isolated by collagenase digestion of the gland, separated from the digest by density gradient centrifugation, and handpicked under a stereomicroscope [28]. They were then pre-cultured for 1 week at 37°C in serum-free RPMI 1640 medium (Gibco, Grand Island, NY, USA) containing G10 and 5 g/l BSA (fraction V, Roche, Basel, Switzerland), 100 IU/ml penicillin, and 100 μg/ml streptomycin in the presence of 5% CO2. Large islets (>150- to 200-μm diameter) that frequently develop central necrosis were discarded. After preculture, the islets were further cultured in the same medium containing 5 mmol/l glucose (G5), G10 or G30 and various test substances. This test period lasted from 15 min up to 8 days, so that the total duration of culture never exceeded 15 days. In all cases, the medium was renewed after 1 day, then every other day. At the end of the culture, a portion of the medium was withdrawn for insulin secretion measurement, and the islets were processed for measurement of NFκB DNA binding activity or mRNA levels.

All experiments were conducted in accord with accepted standards of humane animal care and were approved by the Institutional Committee on Animal Experimentation from the Faculty of Medicine of the University of Louvain.

Measurement of islet NFκB DNA binding activity

After culture, batches of 100 islets were washed three times in ice-cold PBS (10 mmol/l phosphate buffer, pH 7.5, 150 mmol/l NaCl), followed by rapid centrifugation for 4 min at 1,000 g. The TransAM NFκB ELISA kit (Active Motif, Rixensart, Belgium) was then used for whole islet cell extract preparation and measurement of NFκB (p65) DNA-binding activity according to the manufacturer’s instructions. A 30-min exposure to 50 IU/ml IL-1β in the presence of G10 was used as a positive control condition for islet NFκB activation. The TransAM NFκB ELISA kit was validated by comparing its results with those obtained by electrophoretic mobility shift assay using an NFκB consensus oligonucleotide [36]. Comparable results were obtained with both methods in insulin-producing RINm5 cells exposed to IL-1β for 30 min. Moreover, the signal intensity of NFκB activation detected by the ELISA kit was proportional to the number of IL-1β-treated cells in RINm5 cells, INS-1 cells and primary beta cells (25, 50 and 100×103 cells) (data not shown).

RNA extraction and cDNA synthesis

Islet total RNA was extracted and reverse transcribed into cDNA, as previously described [27, 28], using random hexamers and 200 units of M-MLV Reverse Transcriptase RNase H Point Mutant (Promega, Madison, WI, USA).

Duplex radioactive PCR

TATA-box binding protein (TBP) was used as a housekeeping gene. The islet HO1 and c-Myc:TBP mRNA ratios were determined by simultaneous amplification of c-Myc or HO1 plus TBP islet cDNAs using a validated radioactive hot-start PCR protocol. The primer sequences, reaction conditions and PCR validation experiments have been reported previously [27, 28]. The PCR products were separated on a 6% PAGE and the amount of [α-32P] dCTP incorporated in each amplimer was quantified with a Cyclone Storage Phosphor System (Packard, Meriden, CT, USA). The ratio “gene/TBP” was calculated for each test condition, and normalised to the same ratio in control islets cultured in G10 within the same experimental series. Relative to total RNA, TBP mRNA levels remained constant under our different experimental conditions, unless otherwise specified.

Real-time fluorescent PCR

Real-time PCR was performed with the iCycler iQ Real-time PCR Detection System (Bio-Rad, Hercules, CA, USA), using the fluorescent dye SYBR green I (Molecular Probe, Leiden, The Netherlands) [37]. cDNA amplifications were performed in duplicates in a 25-μl reaction volume containing 12.5-μl iQ Supermix (Bio-Rad), cDNA (0.25–16 ng total RNA equivalents) or water, 300 nmol/l sense and antisense primers, SYBR Green I at a 10−5 dilution, and 10 nmol/l fluorescein for initial well-to-well fluorescence normalisation. The thermal cycle profile was a 3-min denaturing step at 95°C to release DNA polymerase activity followed by 40 cycles of amplification, each composed of a 15-s denaturation step at 95°C, a 45- to 60-s annealing step at 60–62°C, and an eventual 15-s step at 82–83°C (Table 1). After amplification, the specificity of PCR products was verified by melting curve analysis [38], and the threshold cycle was determined using iCycler iQ software 3.0a (Bio-Rad). Under these conditions, PCR efficiencies ranged from 0.95 to 1.0. Within each PCR, “gene” mRNA levels were determined by comparison with a standard curve prepared by serial 4-fold dilutions of an appropriate control cDNA (Table 1), and expressed relative to the mRNA levels in control islets cultured in G10.
Table 1

Sequences of oligonucleotide primers and reaction conditions for real-time PCR, and characteristics of PCR products

Gene

5′-Sense primer-3′

5′-Antisense primer-3′

Inputa

Standard curve cDNAb

Annealing (°C–s)

Extension (°C–s)

Size (bp)

Tm (°C)

Fas

TGA.GCC.TTG.CAC.ACG.AAC

CAC.AAC.AGC.CCC.CAA.GAT

16

Control islets

62–45

82–15

322

85.0

iNOS

TGA.CCT.GAA.AGA.GGA.AAA.GGA

CAC.GTG.AGG.ATC.AAA.AAC.TGG

16

IL-1β treated islets

60–45

83–15

200

88.0

IκBα

TGG.TCT.CGC.TCC.TGT.TGA.AG

GTA.AGC.TGG.TAG.GGG.GAG.TAG

4

IL-1β treated islets

62–45

82–15

76

85.0

ProIL-1β

GAT.GAT.GAC.GAC.CTG.CTA.GTG.T

GTT.GGC.TTA.TGT.TCT.GTC.CAT.TGA.G

16

LPS-rat liver

62–60

none

142

84.5

TBP

ACC.CTT.CAC.CAA.TGA.CTC.CTA.TG

ACT.TCG.TGC.CAG.AAA.TGC.TGA

4–16

variable

variable

variable

157

85.5

Tm melting temperature

aIslet sample cDNA input per tube (ng total RNA equivalent)

bThe standard curve cDNA was either prepared from control precultured islets eventually treated for 6 h with 50 IU/ml IL-1β, or prepared from the liver of a rat infected with lipopolysaccharide (LPS-rat) [58]

Primers

Except for Fas primers [12], pairs of primers were designed using Hybsimulator 4.0 software (Advanced Gene Computing Technologies, Irvine, CA, USA). The specificity of sense and antisense primers (Table 1) was checked by BLAST search on the Genbank database. For each gene studied, the size of the amplicon corresponded to the expected one, based on published sequences.

Measurement of insulin secretion

Insulin concentrations in the culture media were assayed by radioimmunoassay using rat insulin as a standard [39].

Data analysis

Results are means±SEM for the indicated number of independent experiments. Statistical analysis was performed using unpaired Student’s t-test when only two groups were compared, one-way ANOVA followed by a Newman–Keuls test, or two-way ANOVA as indicated. Differences were considered significant at a p value of less than 0.05.

Results

Time-dependent effect of high glucose on islet HO1 and c-Myc mRNA levels

After 1-week preculture in the presence of G10, further culture in G30 instead of G10 induced a time-dependent increase in islet HO1 and c-Myc/TBP mRNA ratios that persisted for at least up to 3 days (Fig. 1 and Table 2, series 1). These increases were also observed in freshly isolated islets cultured for 1 week in G30 instead of G10 (Table 2, series 2). Significant increases in islet HO1 and c-Myc/TBP mRNA ratios were also induced by a 6-h exposure to IL-1β in the presence of G10 (Table 2).
Fig. 1

Time-dependent effect of 30 mmol/l glucose on islet HO1 mRNA levels. After 1-week preculture in 10 mmol/l glucose (G10), rat islets were cultured for 2–24 h (a) or 18 and 72 h (b) in G10 or 30 mmol/l glucose (G30) (open or closed circles respectively). At the end of culture, the islet HO1/TBP mRNA ratio was determined and expressed relative to the ratio in islets cultured for 24 h (a) or 18 h (b) in G10 (dotted line). Data are means±SEM for four independent experiments. *p<0.05 or less vs islets cultured in G10

Table 2

Comparison of the effects of 30 mmol/l glucose and IL-1β on islet HO1 and c-Myc/TBP mRNA ratios (relative to 10 mmol/l glucose)

Gene

Experimental series 1

Experimental series 2

G10 (18 h), n=8

G30 (18 h), n=8

G10+IL-1β (6 h), n=3

G10 (1 week), n=6–7

G30 (1 week), n=6–7

HO1/TBP

1.00±0.16

5.10±1.16a

2.16±0.46a

1.00±0.27

3.55±0.59a

c-Myc/TBP

1.00±0.22

3.99±0.39a

5.11±0.62a

1.00±0.19

2.52±0.61a

In series 1, rat islets were first precultured in G10 as described above, before being further cultured for 18 h in the presence of G10 or G30, or treated with 50 IU/ml IL-1β for the last 6 h of culture in G10 (G10+IL-1β). In series 2, immediately after isolation, rat islets were cultured for 1 week in the presence of G10 or G30. At the end of culture, islet c-Myc and HO1/TBP mRNA ratios were determined by duplex radioactive RT-PCR and expressed relative to the ratio measured in islets cultured in G10. Data are means±SEM for the indicated number of independent observations

G10 10 mmol/l glucose, G30 30 mmol/l glucose

ap<0.05 or less vs islets cultured in G10 by unpaired t-test

Effect of high glucose on NFκB (p65) DNA binding activity

After 1-week preculture in G10, islet NFκB (p65) DNA binding activity was not significantly affected by further culture in G5, G10 or G30 for 15, 30 or 60 min (data not shown, n=3), 1–24 h, and 1–8 days (Fig. 2a and b). Under these conditions, glucose markedly stimulated insulin secretion in a concentration-dependent manner (Fig. 2c and d; two-way ANOVA, p<0.001 or less for the glucose effect, p>0.2 for the time effect). Contrasting with the absence of a glucose effect, a 30-min exposure to IL-1β in the presence of G10 strongly and consistently activated NFκB DNA binding activity in these islets (p<0.01 or less at each time point, n=3). Similar results were obtained using RPMI medium containing 10% heat-inactivated calf serum instead of BSA for preculture and culture of the islets (data not shown).
Fig. 2

Time-dependent effect of glucose on NFκB (p65) DNA binding activity and insulin secretion in cultured rat islets. After preculture in 10 mmol/l glucose, rat islets were cultured for 1–24 h (a, c) or 1–8 days (b, d) in the presence of 5 mmol/l glucose (G5, hatched columns), 10 mmol/l glucose (G10, open columns) or 30 mmol/l glucose (G30, filled columns). At several time points, islets cultured in G10 were treated for the last 30 min with 50 IU/ml IL-1β (G10+IL-1β, cross-hatched columns). Cellular extracts (a, b) were prepared, and the DNA binding activity of the p65 subunit of NFκB was measured by an ELISA as described above. Within each experiment, the absorbance value obtained for islets cultured in G10 was subtracted from the absorbance value for other groups of islets; results from islets cultured in G10 are shown as 0±SEM (second column at each time point). At the end of culture, insulin concentration (c) was measured in the medium by RIA and the rate of secretion per hour of culture was calculated. d. Hourly rate of insulin secretion over the last 2 days of culture. Results are means±SEM for three independent experiments

Effects of high glucose on islet mRNA levels of various NFκB-dependent genes

In the experiments in which islet c-Myc and HO1/TBP mRNA ratios were significantly increased by G30 and IL-1β (Table 2), TBP, iNOS and IκBα mRNA levels were not significantly affected by glucose, whereas Fas mRNA levels were slightly decreased after overnight culture in G30, and significantly increased after 1 week under these conditions (Table 3). In comparison, a 6-h exposure to IL-1β in the presence of G10 consistently increased islet Fas, iNOS and IκBα without affecting TBP mRNA levels.
Table 3

Comparison of the effects of 30 mmol/l glucose, IL-1β and hydrogen peroxide on islet mRNA levels of TBP and various NFκB target genes (relative to 10 mmol/l glucose)

Gene

Experimental series 1

Experimental series 2

G30/G10 (18 h), n=8a

G10+IL-1β/G10 (6 h), n=3

G10+H2O2 /G10 (18 h), n=4

G30/G10 (1 week), n=6–7

TBP

1.13±0.04

1.1±0.2

0.98±0.07

1.00±0.07

Fas

0.81±0.11b

7.7±1.2b,c

1.16±0.20

2.66±0.35b

iNOSd

1.00±0.36

718±112b,c

2.86±0.77b

1.36±0.34

IκBα

1.14±0.12

13.9±9.7c

1.48±0.10b

0.97±0.22

proIL-1β

0.68±0.21b

7.2±2.5c

0.74±0.32

1.02±0.30

In series 1, rat islets were first precultured in G10 as described above, before being further cultured for 18 h in the presence of G10, G30 or G10+5 μmol/l H2O2 (G10+H2O2), or treated with 50 IU/ml IL-1β for the last 6 h of culture in G10 (G10+IL-1β). In series 2, immediately after isolation, rat islets were cultured for 1 week in the presence of G10 or G30. Islet TBP, Fas, iNOS, IκBα and proIL-1β mRNA levels were determined by real-time RT-PCR and expressed relative to the mRNA levels in islets cultured in G10 for 18 h (three left columns) or 1 week (right column). Data are means±SEM for the indicated number of independent observations

G10 10 mmol/l glucose, G30 30 mmol/l glucose, H2O2 hydrogen peroxide

an=6 for iNOS that was below the detection limit in two out of eight cDNAs from islets cultured in G30

bRelative change in gene mRNA levels significantly different from that in TBP mRNA levels in the same samples, p<0.05 or less by unpaired t-test

cSignificant effect of IL-1β vs G30 and H2O2 on the relative change in gene mRNA levels, p<0.05 or less by one-way ANOVA+Newman–Keuls test

diNOS mRNA expression was very low in islets cultured for 18 h in G10 or G30, with mean±SE threshold cycle values of 29.1±0.6 and 30.4±0.5 respectively

Effects of antioxidants on islet HO1 and c-Myc mRNA induction by G30

After 1-week preculture in G10 and further culture for 18 h in G10 or G30, the addition of a combination of 10 mmol/l NAC and 1 mmol/l aminoguanidine to the medium decreased the islet HO1/TBP mRNA ratio in G10, and completely abrogated its increase by G30. These effects were reproduced by NAC alone, whereas aminoguanidine reduced the islet HO1/TBP mRNA ratio in both G10 and G30 by about 40%, without affecting its relative increase by G30 (Fig. 3a). In another series of experiments, in which rat islets were cultured overnight in the presence of increasing NAC concentrations, the increase in the islet HO1/TBP mRNA ratio produced by G30 was unaffected by 0.01–0.1 mmol/l NAC, but was maximally inhibited by 1–10 mmol/l NAC (n=3, p<0.05 vs G30 alone, data not shown). In a subsequent series of experiments, 1 mmol/l NAC abrogated and reduced by about 50% the stimulatory effect of G30 on islet HO1 and c-Myc/TBP mRNA ratios respectively (Fig. 3b and c).
Fig. 3

Effect of antioxidants and hydrogen peroxide on the stimulation of islet HO1 and c-Myc mRNA expression by 30 mmol/l glucose. a After preculture in 10 mmol/l glucose (G10), rat islets were cultured for 18 h in the presence of G10 (open columns) or 30 mmol/l glucose (G30, grey columns) with or without 10 mmol/l N-acetyl-l-cysteine (NAC) and 1 mmol/l aminoguanidine (AG) as indicated. b, c The islets were cultured for 18 h in G10 (open columns) or G30 (filled columns) with or without 5 μmol/l hydrogen peroxide (H2O2) in the presence or absence of 1 mmol/l NAC. At the end of culture, islet total RNA was extracted and the HO1 and c-Myc/TBP mRNA ratios, determined by duplex RT-PCR, were expressed relative to the ratio in islets cultured in G10. Data are means for two experiments plus individual data points (a) or means±SEM for three independent experiments (b, c). aSignificant effect of G30 (p≤0.05); bsignificant effect of H2O2 (p≤0.05); csignificant effect of NAC (p≤0.05)

Effects of hydrogen peroxide on islet HO1 and c-Myc mRNA levels

After 1-week preculture in G10 and further culture for 18 h in G10 plus increasing concentrations of H2O2, the islet HO1 and c-Myc/TBP mRNA ratios were unaffected by 0.2–1 μmol/l H2O2, but were increased by 5 μmol/l H2O2 (n=3, p<0.01 vs G10 alone, data not shown). Higher concentrations of H2O2 (10–25 μmol/l) induced macroscopical alterations of the islets, reduced the amount of total RNA recovered per islet, and decreased the mRNA expression of TBP relative to the input of cDNA (data not shown). These alterations prevented reliable determination of changes in islet HO1 and c-Myc mRNA levels after islet treatment with a high concentration of H2O2. In a subsequent series of experiments, the stimulatory effect of 5 μmol/l H2O2 on islet HO1 and c-Myc mRNA levels was synergistic with that of G30, and was abrogated by 1 mmol/l NAC (Fig. 3b and c).

Effects of H2O2 on islet NFκB (p65) DNA binding activity and mRNA levels of various NFκB-dependent genes

After 1-week preculture in G10, further culture for 15 min to 18 h in the presence of G10 and 5 μmol/l H2O2 did not stimulate islet NFκB (p65) DNA binding activity, in contrast to a 30-min exposure to 50 IU/ml IL-1β (Fig. 4). Accordingly, islet Fas and IκBα mRNA levels were not, or only slightly, increased by culture for 18 h in the presence of 5 μmol/l H2O2. Under these conditions, islet iNOS mRNA levels were increased to a much lesser extent by H2O2 than by IL-1β (∼3-fold vs ∼700-fold increase respectively) (Table 3, series 1).
Fig. 4

Effect of hydrogen peroxide on islet NFκB (p65) DNA binding activity. After preculture, rat islets were cultured for 15 min up to 18 h in the presence of 10 mmol/l glucose (G10) and 5 μmol/l hydrogen peroxide (filled columns). Control islets cultured in G10 were treated with 50 IU/ml IL-1β for the last 30 min of culture (G10+IL-1β, cross-hatched column). Cellular extracts were prepared, and the DNA binding activity of the p65 subunit of NFκB was measured as described above. Within each experiment, the absorbance value obtained for islets cultured in G10 was subtracted from the absorbance value for other groups of islets; results from islets cultured in G10 are shown as 0±SEM (on the left of G10+IL-1β data). Data are means±SEM for four independent experiments

Effect of high glucose, H2O2 and IL-1β on proIL-1β mRNA expression

After 1-week preculture, islet proIL-1β mRNA levels were not increased by further culture in G30 or G10+5 μmol/l H2O2. In contrast, a 30-min exposure to 50 IU/ml IL-1β markedly increased islet proIL-1β mRNA levels (Table 3).

Effect of p38MAPK and ERK pathway inhibition on islet HO1 and c-Myc mRNA expression

After 1-week preculture, the addition of an inhibitor of p38MAPK (SB203580) or of ERK activation (PD98059) to the culture medium did not affect glucose stimulation of insulin secretion during culture, but reduced by about 50% the stimulation of islet HO1 (and to a lesser extent c-Myc) mRNA expression by G30 as compared to G10 (Fig. 5).
Fig. 5

Effect of inhibitors of p38MAPK and ERK activation on the stimulation of islet HO1 and c-Myc mRNA expression by 30 mmol/l glucose. After preculture, rat islets were cultured for 18 h in the presence of 10 mmol/l glucose (G10) and 30 mmol/l glucose (G30) alone (open columns), G10 and G30 with 10 μmol/l SB203580 (hatched columns), or G10 and G30 with 50 μmol/l PD98059 (filled columns). At the end of culture, islet total RNA was extracted and the HO1 (a) and c-Myc/TBP (b) mRNA ratios, determined by duplex RT-PCR, were expressed relative to the ratio in islets cultured in G10. At the end of culture, insulin concentration (c) was measured in the medium by RIA and the rate of secretion per hour of culture was calculated. Data are means±SEM for three independent experiments. aSignificant effect of G30 (p<0.05); bsignificant effect of test agent in G30 (p<0.05)

Discussion

This study was performed with rat islets precultured for 1 week in serum-free RPMI medium containing G10. This preculture is routinely used in our lab because it preserves glucose stimulus-secretion coupling events and islet cell morphology [40] while allowing islet recovery from the stress of isolation [27, 28]. As such, it is an important condition to detect an effect of high glucose on islet expression of stress-induced genes such as c-Myc and HO1, two genes that are early markers of alterations induced by high glucose in beta cell gene expression [11, 12, 27, 28].

Our results demonstrate that the in vitro stimulation of rat islet HO1 and c-Myc mRNA expression by supraphysiological glucose occurs without activation of the p65 subunit of NFκB, which has been previously shown to be the crucial component of the activated NFκB complex in pancreatic beta cells [41, 42]. Accordingly, islet mRNA expression of NFκB target genes such as iNOS and IκBα were not affected by overnight and 1-week culture in G30 as compared to G10, whereas Fas was increased after 1 week only. These results make it unlikely that other NFκB subunits (p50, c-Rel) migrate to the nucleus and compensate for the lack of p65 activation under these culture conditions. In contrast with G30, IL-1β consistently and markedly increased islet NFκB DNA binding activity and mRNA expression of all NFκB target genes tested under our culture conditions, in agreement with studies on the effects of IL-1β in purified rat beta cells [17, 19, 20]. Therefore, our results do not support our previous hypothesis that the stimulation of islet HO1 and c-Myc expression by high glucose might result from NFκB activation [28].

It could be argued that we failed to detect an effect of glucose on rat islet NFκB DNA binding activity because this activation is transient. However, islet HO1 and c-Myc expression were maximally induced after 18–24 h and remained elevated after several days of culture in G30, whereas islet NFκB activity was not increased after 15 min up to 8 days of culture in high glucose. It could also be argued that the sensitivity of the assay was too low. However, glucose did not affect islet mRNA levels of iNOS and IκBα, two NFκB target genes induced about 700- and 15-fold by IL-1β. It is therefore unlikely that high glucose would activate islet NFκB without inducing a detectable increase in iNOS and IκBα mRNA levels. Finally, the lack of glucose effect on islet NFκB DNA binding activity was confirmed in rat islets exposed to G30 instead of G10 for 1–4 days in serum-containing RPMI, and in FACS-purified rat beta cells (attached to poly-lysine-coated dishes) exposed to high glucose for 12–24 h, thereby excluding the possibility that our results are due to the absence of serum or lack of islet cell attachment during culture. In the latter type of experiments, NFκB activation was evaluated by immunofluorescent determination of the cytoplasmic and nuclear localisation of NFκB, as previously described [43]. Thus, after 12–24 h of culture in G28 vs G5–G10, NFκB remained localised in the cytoplasm, whereas it was mainly localised in the nucleus after IL-1β treatment (cytoplasmic localisation in 99.6±0.4 and 99.2±0.5% of the cells cultured for 24 h in G10 and G30 respectively, n=3, p>0.05; nuclear localisation in 95.6±2.2 vs 0.4±0.4% of the cells exposed to IL-1β vs controls, n=3, p<0.001).

Interestingly, hydrogen peroxide reproduced the effect of G30 on islet HO1 and c-Myc mRNA expression without activating NFκB, while the antioxidant NAC reduced or abrogated these effects of G30 and/or hydrogen peroxide. Although an increase in production of reactive oxygen species was not directly demonstrated under our particular culture conditions, these data nevertheless suggest that oxidative stress is involved in the stimulation of islet HO1 and c-Myc mRNA expression by hyperglycaemia, but through the activation of transcription factor(s) other than NFκB. Although it is usually accepted that oxidative stress activates NFκB, such a causal link has been recently challenged [44]. Besides NFκB DNA binding sites, rat hmox1 and c-Myc gene promoters contain consensus sequences for binding of other transcription factors activated by oxidative stress, i.e. AP1, CREB, ATF4, HIF, SRE, etc. [45, 46]. In this regard, while the stimulation of c-Myc expression by high glucose could result from the activation of PKCβ2 [47], our preliminary results indicate that the stimulation of islet HO1 expression may involve glucose activation of both p38MAPK and ERK [48].

A role of oxidative stress in the stimulation of islet HO1 and c-Myc expression by G30 is compatible with a recent study showing that culture in high glucose increases reactive oxygen species production in rat pancreatic islets [33]. It is also compatible with earlier reports on the beneficial effect of antioxidants, including NAC, on beta cell glucose toxicity in models of type 2 diabetes [32, 33, 49, 50]. It should be noted, however, that very high NAC or cysteine concentrations can be detrimental (pro-oxidant?) to pancreatic beta cells [51].

It has recently been reported that NFκB activation and subsequent stimulation of beta cell apoptosis in isolated human islets cultured for a few days in high glucose result from an increase in beta cell production of IL-1β with autocrine effects [35]. These observations, together with similarities between the effects of cytokines and high glucose on beta cell gene expression, have led to the proposal that type 2, like type 1 diabetes, is a chronic inflammatory disease [52]. Our finding that NFκB activity (using the same ELISA kit as in [35]) is not affected by glucose in cultured rat islets markedly contrasts with these results. Another difference with regard to the observations in human islets is that proIL-1β mRNA expression by rat islets was unaffected by G30 or hydrogen peroxide although it was induced by IL-1β. The stimulatory effect of IL-1β on its own expression was not reproduced in FACS-purified rat beta cells [53] (Liu and Eizirik, unpublished data), and could thus occur in non-beta cells of the islet. Whatever the cell type involved in this response, these results indicate that, under our experimental conditions, G30 did not stimulate IL-1β release by rat islets.

The reasons for the discrepancy between our and the above-mentioned studies are unclear. We consider the species difference (rat vs human) an unlikely explanation, because prolonged culture in G30 instead of G10 induces similar alterations of glucose-stimulated-insulin secretion in rat and human islets [9, 10, 40]. Moreover, in three well characterised human islet preparations containing more than 50% insulin-positive beta cells, culture in 28 instead of 5.6 mmol/l glucose for 2 or 7 days failed to induce mRNA expression of the NFκB target genes Fas and IL-1β, indicating that NFκB was not activated in human islets under these culture conditions (Welsh et al., preliminary observations). Of note, Fas and IL-1β mRNAs were detected at 30- and 100-fold higher levels respectively in stimulated human dendritic cells. Regarding the differences in culture conditions, we have shown that glucose does not activate rat islet NFκB in various culture systems (with or without serum, floating or attached whole islets, dispersed cells attached to poly-lysine coated dishes). Our current hypothesis is that culturing human islets spread on an extracellular matrix [35] permits long-term survival/proliferation of non-endocrine cells that inevitably contaminate human islet preparations [54]. It is possible that hyperglycaemia activates the p65 subunit of NFκB, in a manner dependent on oxidative stress, in duct cells, endothelial cells, or fibroblasts [55, 56, 57]. In contrast, our culture of floating islets in serum-free medium allows optimal survival of endocrine cells in the absence of contaminating cell types, as judged by optical and electron microscopy of islet sections [40]. The conserved islet structure (floating round islets with central beta cells and peripheral non-beta cells) should also preserve beta cell interactions with their neighbouring beta cells and with components of the extracellular matrix [40]. Further studies are definitely required before one can conclude that one culture system is more appropriate than the other for the in vitro study of islet cell (patho)physiology.

In conclusion, supraphysiological glucose concentrations stimulate c-Myc and HO1 expression without activating NFκB in cultured rat islets. This strongly suggests that IL-1β receptor-mediated activation of NFκB is not involved in the functional alterations of rat and human beta cells cultured under similar conditions [9, 10, 40]. Data from our present and previous studies [27, 28] on the stimulation of rat islet c-Myc and HO1 expression by G30 are summarised in Fig. 6. Altogether, these results suggest that the stimulation of islet c-Myc and HO1 mRNA expression by high glucose results from the activation of a signalling pathway that is dependent on Ca2+, cyclic AMP and oxidative stress, and independent of NFκB activation. The respective role and potential overlap of these pathways in high-glucose-induced alterations of the beta cell phenotype remain to be clarified.
Fig. 6

Pathways involved in the stimulation of rat islet HO1 and c-Myc expression by high glucose concentrations. The stimulation of rat islet c-Myc and HO1 expression by 30 mmol/l glucose is inhibited by substances that reduce Ca2+ influx (diazoxide and nimodipine), and by the α2-adrenergic agonist clonidine, which inhibits adenylate cyclase in beta cells [27, 28]. It is also inhibited by the antioxidant N-acetyl-l-cysteine (this study). The increase in c-Myc and HO1 expression, which can be reproduced by membrane permeant dibutyryl cyclic AMP and by low concentrations of hydrogen peroxide, occurs in the absence of IL-1β production or NFκB activation. In contrast, IL-1β markedly activates rat islet NFκB and strongly increases islet mRNA levels of iNOS, IκBα and Fas. Protein kinases (PKCβ2, p38MAPK, ERK, etc.) potentially involved in these pathways are not depicted on this scheme. ROS, reactive oxygen species. [Ca2+]c Cytosolic Ca2+ concentration, cAMP cyclic AMP

Notes

Acknowledgements

We thank A. Dannau and F. Knockaert for expert technical help, and I. Kharroubi for helping with the determination of NFκB activation by immunohistochemistry. This work was supported by Grants 3.4552.98, 1.5.182.04 and 3.4514.03 from the Fonds National de la Recherche Scientifique (Brussels), the Interuniversity Poles of Attraction Program (P5/17)-Belgian Science Policy, Grant ARC 00/05-260 from the General Direction of Scientific Research of the French Community of Belgium, and a Johnson and Johnson Type 2 Diabetes Research Grant award from the European Foundation for the Study of Diabetes. J.C. Jonas is Senior Research Associate of the Fonds National de la Recherche Scientifique (Brussels).

References

  1. 1.
    Kahn SE (2003) The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3–19CrossRefPubMedGoogle Scholar
  2. 2.
    Buchanan TA (2003) Pancreatic β-cell loss and preservation in type 2 diabetes. Clin Ther 25(Suppl B):B32–B46CrossRefGoogle Scholar
  3. 3.
    Rahier J, Goebbels RM, Henquin JC (1983) Cellular composition of the human diabetic pancreas. Diabetologia 24:366–371CrossRefGoogle Scholar
  4. 4.
    Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMedGoogle Scholar
  5. 5.
    Leahy JL (1996) Detrimental effects of chronic hyperglycemia on the pancreatic β-cell. In: LeRoith D, Taylor SI, Olefsky JM (eds) Diabetes mellitus, a fundamental and clinical text. Lippincott-Raven, Philadelphia, pp 103–113Google Scholar
  6. 6.
    Kaiser N, Leibowitz G, Nesher R (2003) Glucotoxicity and β-cell failure in type 2 diabetes mellitus. J Pediatr Endocrinol Metab 16:5–22PubMedGoogle Scholar
  7. 7.
    Eizirik DL, Mandrup-Poulsen T (2001) A choice of death—the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44:2115–2133CrossRefPubMedGoogle Scholar
  8. 8.
    Tokuyama Y, Sturis J, DePaoli AM et al (1995) Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44:1447–1457PubMedGoogle Scholar
  9. 9.
    Ling Z, Pipeleers DG (1996) Prolonged exposure of human β cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest 98:2805–2812Google Scholar
  10. 10.
    Ling Z, Kiekens R, Mahler T et al (1996) Effects of chronically elevated glucose levels on the functional properties of rat pancreatic β-cells. Diabetes 45:1774–1782Google Scholar
  11. 11.
    Jonas JC, Sharma A, Hasenkamp W et al (1999) Chronic hyperglycemia triggers loss of pancreatic β cell differentiation in an animal model of diabetes. J Biol Chem 274:14112–14121CrossRefPubMedGoogle Scholar
  12. 12.
    Laybutt DR, Kaneto H, Hasenkamp W et al (2002) Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to β-cell survival during chronic hyperglycemia. Diabetes 51:413–423Google Scholar
  13. 13.
    Piro S, Anello M, Di Pietro C et al (2002) Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51:1340–1347CrossRefGoogle Scholar
  14. 14.
    Poitout V, Robertson RP (2002) Minireview: secondary β-cell failure in type 2 diabetes—a convergence of glucotoxicity and lipotoxicity. Endocrinology 143:339–342PubMedGoogle Scholar
  15. 15.
    Kosaka K, Kuzuya T, Akanuma Y, Hagura R (1980) Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia 18:23–28CrossRefGoogle Scholar
  16. 16.
    U.K. Prospective Diabetes Study Group (1995) U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44:1249–1258Google Scholar
  17. 17.
    Ling Z, Van de Casteele M, Eizirik DL, Pipeleers DG (2000) Interleukin-1β-induced alteration in a β-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes 49:340–345Google Scholar
  18. 18.
    Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL (2001) Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes 50:909–920PubMedGoogle Scholar
  19. 19.
    Heimberg H, Heremans Y, Jobin C et al (2001) Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes 50:2219–2224PubMedGoogle Scholar
  20. 20.
    Cardozo AK, Heimberg H, Heremans Y et al (2001) A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J Biol Chem 276:48879–48886CrossRefPubMedGoogle Scholar
  21. 21.
    Pelengaris S, Khan M, Evan GI (2002) Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109:321–334CrossRefGoogle Scholar
  22. 22.
    Laybutt DR, Weir GC, Kaneto H et al (2002) Overexpression of c-Myc in β-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes. Diabetes 51:1793–1804PubMedGoogle Scholar
  23. 23.
    Van de Casteele M, Kefas BA, Cai Y et al (2003) Prolonged culture in low glucose induces apoptosis of rat pancreatic β-cells through induction of c-myc. Biochem Biophys Res Commun 312:937–944CrossRefGoogle Scholar
  24. 24.
    Ye J, Laychock SG (1998) A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1β. Endocrinology 139:4155–4163CrossRefGoogle Scholar
  25. 25.
    Pileggi A, Molano RD, Berney T et al (2001) Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50:1983–1991Google Scholar
  26. 26.
    Tobiasch E, Gunther L, Bach FH (2001) Heme oxygenase-1 protects pancreatic β cells from apoptosis caused by various stimuli. J Investig Med 49:566–571Google Scholar
  27. 27.
    Jonas JC, Laybutt DR, Steil GM et al (2001) High glucose stimulates early response gene c-Myc expression in rat pancreatic β cells. J Biol Chem 276:35375–35381CrossRefGoogle Scholar
  28. 28.
    Jonas JC, Guiot Y, Rahier J, Henquin JC (2003) Haeme-oxygenase 1 expression in rat pancreatic β-cells is stimulated by supraphysiological glucose concentrations and by cyclic AMP. Diabetologia 46:1234–1244CrossRefGoogle Scholar
  29. 29.
    Efanova IB, Zaitsev SV, Zhivotovsky B et al (1998) Glucose and tolbutamide induce apoptosis in pancreatic β-cells—a process dependent on intracellular Ca2+ concentration. J Biol Chem 273:33501–33507CrossRefPubMedGoogle Scholar
  30. 30.
    Kefas BA, Heimberg H, Vaulont S et al (2003) AICA-riboside induces apoptosis of pancreatic β cells through stimulation of AMP-activated protein kinase. Diabetologia 46:250–254Google Scholar
  31. 31.
    Matsuoka T, Kajimoto Y, Watada H et al (1997) Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99:144–150Google Scholar
  32. 32.
    Kaneto H, Kajimoto Y, Miyagawa J et al (1999) Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes 48:2398–2406PubMedGoogle Scholar
  33. 33.
    Tanaka Y, Tran PO, Harmon J, Robertson RP (2002) A role for glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci U S A 99:12363–12368CrossRefGoogle Scholar
  34. 34.
    Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H (2003) Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52:581–587PubMedGoogle Scholar
  35. 35.
    Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851–860CrossRefPubMedGoogle Scholar
  36. 36.
    Darville MI, Ho YS, Eizirik DL (2000) NF-kappaB is required for cytokine-induced manganese superoxide dismutase expression in insulin-producing cells. Endocrinology 141:153–162CrossRefGoogle Scholar
  37. 37.
    Bustin SA (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25:169–193PubMedGoogle Scholar
  38. 38.
    Ririe KM, Rasmussen RP, Wittwer CT (1997) Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 245:154–160CrossRefPubMedGoogle Scholar
  39. 39.
    Heding LG (1972) Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8:260–266Google Scholar
  40. 40.
    Khaldi MZ, Guiot Y, Gilon P, Henquin JC, Jonas JC (2004) Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for one week in high glucose. Am J Physiol Endocrinol Metab 287:E207–E217CrossRefGoogle Scholar
  41. 41.
    Darville MI, Eizirik DL (2001) Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kappaB and C/EBP. Diabetes 50:1741–1748PubMedGoogle Scholar
  42. 42.
    Kutlu B, Darville MI, Cardozo AK, Eizirik DL (2003) Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic β-cells. Diabetes 52:348–355Google Scholar
  43. 43.
    Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL (2004) Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of NF-kappa B and endoplasmic reticulum stress. Endocrinology 145:5087–5096CrossRefGoogle Scholar
  44. 44.
    Bowie A, O’Neill LA (2000) Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59:13–23CrossRefGoogle Scholar
  45. 45.
    Kaneto H, Xu G, Fujii N, Kim S, Bonner-Weir S, Weir GC (2002) Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J Biol Chem 277:30010–30018PubMedGoogle Scholar
  46. 46.
    Tacchini L, Fusar-Poli D, Bernelli-Zazzera A (2002) Activation of transcription factors by drugs inducing oxidative stress in rat liver. Biochem Pharmacol 63:139–148CrossRefGoogle Scholar
  47. 47.
    Kaneto H, Suzuma K, Sharma A, Bonner-Weir S, King GL, Weir GC (2002) Involvement of protein kinase C β2 in c-myc induction by high glucose in pancreatic β-cells. J Biol Chem 277:3680–3685CrossRefGoogle Scholar
  48. 48.
    Burns CJ, Squires PE, Persaud SJ (2000) Signaling through the p38 and p42/44 mitogen-activated families of protein kinases in pancreatic beta-cell proliferation. Biochem Biophys Res Commun 268:541–546CrossRefGoogle Scholar
  49. 49.
    Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A 96:10857–10862CrossRefGoogle Scholar
  50. 50.
    Wu L, Nicholson W, Knobel SM et al (2004) Oxidative stress is a mediator of glucose toxicity in insulin-secreting pancreatic islet cell lines. J Biol Chem 279:12126–12134CrossRefGoogle Scholar
  51. 51.
    Rasilainen S, Nieminen JM, Levonen AL, Otonkoski T, Lapatto R (2002) Dose-dependent cysteine-mediated protection of insulin-producing cells from damage by hydrogen peroxide. Biochem Pharmacol 63:1297–1304CrossRefGoogle Scholar
  52. 52.
    Donath MY, Storling J, Maedler K, Mandrup-Poulsen T (2003) Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81:455–470CrossRefGoogle Scholar
  53. 53.
    Liu D, Cardozo AK, Darville MI, Eizirik DL (2002) Double-stranded RNA cooperates with interferon-gamma and IL-1β to induce both chemokine expression and nuclear factor-kappa B-dependent apoptosis in pancreatic β-cells: potential mechanisms for viral-induced insulitis and beta-cell death in type 1 diabetes mellitus. Endocrinology 143:1225–1234CrossRefGoogle Scholar
  54. 54.
    Lefebvre VH, Otonkoski T, Ustinov J, Huotari MA, Pipeleers DG, Bouwens L (1998) Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for β-cells. Diabetes 47:134–137Google Scholar
  55. 55.
    Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790CrossRefPubMedGoogle Scholar
  56. 56.
    Bierhaus A, Schiekofer S, Schwaninger M et al (2001) Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50:2792–2808PubMedGoogle Scholar
  57. 57.
    Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 52:1–8Google Scholar
  58. 58.
    Colson A, Willems B, Thissen JP (2003) Inhibition of TNF-α production by pentoxifylline does not prevent endotoxin-induced decrease in serum IGF-I. J Endocrinol 178:101–109PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • H. Elouil
    • 1
  • A. K. Cardozo
    • 2
  • D. L. Eizirik
    • 2
  • J. C. Henquin
    • 1
  • J. C. Jonas
    • 1
  1. 1.Endocrinology and MetabolismUniversité Catholique de Louvain (UCL)BrusselsBelgium
  2. 2.Laboratory of Experimental MedicineUniversité Libre de Bruxelles (ULB)BrusselsBelgium

Personalised recommendations